Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Neurology

Neuro/Psych pharmacology

Adjunctive antidepressants in bipolar depression: A cohort study of six- and twelve-months rehospitalization rates

European Neuropsychopharmacology | Feb 17, 2018 Neuro/Psych pharmacology

Effectiveness of Rotigotine plus intensive and goal-based rehabilitation vs Rotigotine alone in 'de-novo' Parkinsonian subjects: A randomized controlled trial with 18-month follow-up

Journal of Neurology | Feb 17, 2018 Neuro/Psych pharmacology

Levetiracetam monotherapy for the treatment of infants with epilepsy

Seizure - European Journal of Epilepsy | Feb 17, 2018 Neuro/Psych pharmacology

Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients

Journal of Neurology | Feb 16, 2018 Neuro/Psych pharmacology

Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality

International Journal of Clinical Practice | Feb 16, 2018 Neuro/Psych pharmacology

Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study

Journal of the Neurological Sciences | Feb 15, 2018 Neuro/Psych pharmacology

Open-label, add-on trial of cetirizine for neuromyelitis optica

Neurology® Neuroimmunology & Neuroinflammation | Feb 14, 2018 Neuro/Psych pharmacology

Efficacy of lacosamide in children and adolescents with drug-resistant epilepsy and refractory status epilepticus: A systematic review

Seizure - European Journal of Epilepsy | Feb 09, 2018 Neuro/Psych pharmacology

Dose-related target occupancy and effects on circuitry, behavior, and neuroplasticity of the glycine transporter-1 inhibitor, PF-03463275, in healthy and schizophrenia subjects

Biological Psychiatry | Feb 01, 2018 Neuro/Psych pharmacology

Efficacy and safety of eslicarbazepine acetate vs controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study

Epilepsia | Jan 30, 2018 Neuro/Psych pharmacology

« Prev 1 … 47 48 49 50 51 … 72 Next »

Adjunctive antidepressants in bipolar depression: A cohort study of six- and twelve-months rehospitalization rates

Effectiveness of Rotigotine plus intensive and goal-based rehabilitation vs Rotigotine alone in 'de-novo' Parkinsonian subjects: A randomized controlled trial with 18-month follow-up

Levetiracetam monotherapy for the treatment of infants with epilepsy

Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients

Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality

Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study

Open-label, add-on trial of cetirizine for neuromyelitis optica

Efficacy of lacosamide in children and adolescents with drug-resistant epilepsy and refractory status epilepticus: A systematic review

Dose-related target occupancy and effects on circuitry, behavior, and neuroplasticity of the glycine transporter-1 inhibitor, PF-03463275, in healthy and schizophrenia subjects

Efficacy and safety of eslicarbazepine acetate vs controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study

New Treatment in Uveitis

Optimising Caesarean Section Practices

MIP: Snake Bite Management: Dr Surajit Giri

The evolving landscape of CDK4/6i therapy in metastatic Breast Cancer: Experts discuss key findings and future directions

Mount Sinai is first in the nation to perform deep brain stimulation implant as part of clinical trial for depression

Adjunctive antidepressants in bipolar depression: A cohort study of six- and twelve-months rehospitalization rates

Effectiveness of Rotigotine plus intensive and goal-based rehabilitation vs Rotigotine alone in 'de-novo' Parkinsonian subjects: A randomized controlled trial with 18-month follow-up

Levetiracetam monotherapy for the treatment of infants with epilepsy

Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients

Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality

Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study

Open-label, add-on trial of cetirizine for neuromyelitis optica

Efficacy of lacosamide in children and adolescents with drug-resistant epilepsy and refractory status epilepticus: A systematic review

Dose-related target occupancy and effects on circuitry, behavior, and neuroplasticity of the glycine transporter-1 inhibitor, PF-03463275, in healthy and schizophrenia subjects

Efficacy and safety of eslicarbazepine acetate vs controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study

New Treatment in Uveitis

Optimising Caesarean Section Practices

MIP: Snake Bite Management: Dr Surajit Giri

The evolving landscape of CDK4/6i therapy in metastatic Breast Cancer: Experts discuss key findings and future directions

Mount Sinai is first in the nation to perform deep brain stimulation implant as part of clinical trial for depression

Select Specialty

Select Topic